Drug recall · March 21, 2018
Hydromorphone recall
Why: Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Hospira, Inc., Lake forest, IL 60045 USA. NDC: 0409-2634-01
- Lots / codes
Lot 71330DD EXP. 11/1/2018.
- Quantity
- 29, 680 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the USA
- Initiated
- February 7, 2018 · Voluntary: Firm initiated
- Classified
- March 14, 2018
- Reported
- March 21, 2018
- Ended
- August 7, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydromorphone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.